Appointment booking for Dr. Celso Velazquez, MD is currently not available.Dr. Celso Velazquez, MD has not yet fully activated their profile on DiabetesIQ.
Dr. Celso Velazquez, MD (he/him) is a Rheumatologist, Pathologist in Columbia, MO with over 18 years of experience. What is your opinion of Dr. Celso Velazquez, MD? Rate this provider below so other people can make informed decision.
Gender
Male
Experience
Over 18 Years of Experience
Languages Spoken
English
Accepted Insurances
Medicare
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Celso Velazquez, MD has received over $2,816 which includes payments from the following companies:
$690.30 from Pfizer Inc.
$376.97 from Janssen Scientific Affairs, LLC
$326.95 from Janssen Biotech, Inc.
$311.91 from Novartis Pharmaceuticals Corporation
$271.86 from Celgene Corporation
$256.52 from Genentech USA, Inc.
$167.70 from Amgen Inc.
$88.83 from Horizon Pharma plc
$63.56 from UCB, Inc.
$52.57 from Radius Health, Inc.
$52.32 from AbbVie, Inc.
$39.65 from E.R. Squibb & Sons, L.L.C.
$37.25 from Boehringer Ingelheim Pharmaceuticals, Inc.
$26.84 from Mallinckrodt LLC
$16.01 from Bayer HealthCare Pharmaceuticals Inc.
$14.92 from DePuy Synthes Sales Inc.
$12.41 from GlaxoSmithKline, LLC.
$10.34 from Actelion Pharmaceuticals US, Inc.
Payments received by Dr. Celso Velazquez, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!